Report Highlights
The global market for healthcare analytics reached $6.2 billion in 2016. This market should reach nearly $7.2 billion in 2017 and $14.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.8%.
Report Includes
- 58 data tables and 20 additional tables
- An overview of the global markets for healthcare analytics
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- A look at how healthcare analytics utilizes systematic data from clinical and business fronts to arrive at insights that are developed with the help of statistical, contextual, quantitative, predictive, and cognitive spectrums
- Evaluations of factors driving the market, such as the introduction of federal healthcare policies, increased focus on data collection and analysis for better customer service, progress in clinical outcomes, rapid technological advances, and the emergence of social media
- Analysis of growth inhibitors, such as data security issues, patient data confidentiality, cultural barriers to IT adoption, and lack of manpower with cross-functional analytical skills
- A look at the role different participants in the industry play, including the government, insurers, medical staff, and physicians
Report Scope
This research report categorizes the healthcare analytics market by type, application, component, end user and delivery model. Applications include financial, clinical, operational and administrative and population health analytics. Components include services, software and hardware. Delivery includes on premise and on demand delivery models. End users include payers, providers and others.
The financial analytics are provided for claims processing; revenue cycle management (RCM); payment integrity and fraud, waste, and abuse (FWA); risk adjustment; and risk assessment. Clinical analytics is provided for quality improvement and clinical benchmarking; clinical decision support; regulatory reporting and compliance; comparative analytics and comparative effectiveness; and performance measurement. Operation and administrative analytics are provided for supply chain analytics, workforce analytics and strategic analytics.
Analyst Credentials
Neha Maliwal is a graduate in biotechnology with an MBA in marketing from Pune University in India.
With more than five years of experience in market research, she has worked as a business analyst across various industries, such as healthcare IT and the U.S. mortgage industry. She has authored many BCC Research reports, with topics including healthcare analytics, antibiotics and sample preparation.
Report Highlights
The global market for healthcare analytics reached $4.8 billion in 2014. This market is forecasted to grow at a compound annual growth rate (CAGR) of 24.0% to reach nearly $16.9 billion in 2020 from nearly $5.8 billion in 2015.
Report Includes
- An overview of the global markets for healthcare analytics.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- A look at how healthcare analytics utilizes systematic data from clinical and business fronts to arrive at insights which are developed with the help of statistical, contextual, quantitative, predictive, and cognitive spectrums.
- Evaluation of factors driving the market such as the introduction of federal healthcare policies, increased focus on data collection and analysis for better customer service, progress in clinical outcomes, rapid technological advances and the emergence of social media.
- Analysis of growth inhibitors such as data security issues, patient data confidentiality, cultural barriers to IT adoption, and lack of manpower with cross-functional analytical skills.
- A look at the role different participants in the industry play including the government, insurers, medical staff, physicians and others.
Related Reports
Pharmacy Automation: Technologies and Global Markets
The global market for pharmacy automation is estimated to increase from $7.8 billion in 2023 to reach $12.7 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Smart Hospitals: Global Markets
The global smart hospitals market should reach $111.99 billion by 2026 from $39.16 billion in 2021 at a compound annual growth rate (CAGR) of 23.4% for the forecast period of 2021 to 2026.
e-Pharmacy: Global Markets
The global e-pharmacy market should grow from $66.1 billion in 2020 to reach $178.4 billion by 2025 at a compound annual growth rate (CAGR) of 22.0% during the period of 2020-2025.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More